title: Haemodialysis is an effective treatment in acute metabolic decompensation of maple syrup urine disease.
abstract: Acute metabolic decompensation in maple syrup urine disease can occur during intercurrent illness and is a medical emergency. A handful of reports in the medical literature describe the use of peritoneal dialysis and haemodialysis as therapeutic inventions. We report the only patient from our centre to have haemodialysis performed in this setting. Combined with dietary BCAA restriction and calorific support, haemodialysis allows rapid reduction in plasma leucine concentrations considerably faster than conservative methods.
authors.affiliation: Stanford University, Dept. of Pediatrics, Div. of Med. Genetics, 300 Pasteur Drive, Stanford, CA, 94305, United States.
authors.forename: P S
authors.initials: PS
authors.lastname: Atwal
authors.affiliation: Stanford University, Dept. of Pediatrics, Div. of Med. Genetics, 300 Pasteur Drive, Stanford, CA, 94305, United States.
authors.forename: C
authors.initials: C
authors.lastname: Macmurdo
authors.affiliation: Stanford University, Dept. of Pediatrics, Div. of Nephrology, 300 Pasteur Drive, Stanford, CA, 94305, United States.
authors.forename: P C
authors.initials: PC
authors.lastname: Grimm
keywords: Acute metabolic crisis; BCAA, branched chain amino acids; BCKD, branched-chain-ketoacid dehydrogenase; Dialysis; Haemodialysis; MSUD, maple syrup urine disease; Maple syrup urine disease